Pharmacokinetics of Posconazole Suspension in Healthy Chinese Subjects Following Single-dose Adminis

来源 :2013中国药学大会暨第十三届中国药师周 | 被引量 : 0次 | 上传用户:djs4520345
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background:Posaconazole (POS) is a broad-spectrum triazole antifungal compound.Systemic exposure is enhanced by approximately 2.6- to 4-fold when POS oral suspension is taken with a nutritional supplement or high-fat meal compared with fasting state.The current study was designed to evaluate safety and tolerability and to determine the relative bioavailability of POS oral suspension under fasting and fed conditions when given to healthy Chinese subjects.Objective: This study was to determine the relative availability of POS suspension and to evaluate the safety and tolerability following single-dose administration with fast or high-fat food in Chinese healthy subjects.Methods: This was a randomized,open-label,single-dose,2 × 2 crossover study.Twelve healthy subjects received one dose of POS oral suspension (5 mL; 200 mg) while fasting or with a high-fat Chinese meal.Plasma concentrations of POS were measured through 120 h after dosing.The measured plasma concentration data were calculated with a noncompartment model,while Cmax and Tmax were measured values.The pharmacokinetic parameters were statistically analyzed using a crossover analysis of variance model.Relative bioavailability based on log-transformed data was expressed as the ratio of the AUC estimates for the suspension in the fed and fasting states.Safety assessments were conducted throughout the study.Results: Of the 12 enrolled subjects,4 were females with a mean age of 22.5 years.Mean Cmax values were 128.02 and 354.29 ng/mL,for fasting and fed conditions,respectively,and corresponding mean AUC0-t values were 3075.27 and 12,229.08 ng · h/mL.Food enhanced exposure with a relative bioavailability of 510% (AUC).Conclusions: Similar to results of previous studies in other populations,significant differences in AUC,Cmax,and Tmax (P< 0.05) were found in Chinese subjects who received oral POS suspension while fasting and after a high-fat meal.The high-fat meal increased Cmax by 3.58-fold and AUC by 5.10-fold,as well as significantly influencing the rate and extent of absorption.A single dose of oral POS suspension was safe and well tolerated in healthy Chinese subjects.
其他文献
目的:观察GLP-1受体激动剂对尾悬吊模拟失重所致大鼠骨质疏松的疗效.方法:采用尾悬吊法建立大鼠模拟失重性骨质疏松模型,腹腔注射GLP-1受体激动剂连续治疗4周.测定血清和尿液中骨代谢相关的生化指标;骨组织形态计量学分析及骨生物力学性能测试;骨组织切片、染色以观察GLP-1受体激动剂是否具有防治失重性骨质疏松的作用.结果:GLP-1受体激动剂能够明显升高血清中骨钙素(OCN)水平和碱性磷酸酶(AL
目的:建立高效液相色谱法测定大鼠血清中视黄醇和视黄酸浓度的方法.方法:色谱柱为Phenomenex C18(150×4.6mm,5μm),流动相为甲醇:10mM乙酸铵缓冲盐(V/V=90:10),流速为1.0mL·min-1,柱温为40℃,检测波长为340nm,进样量20μL,灵敏度0.01AUFS.结果:大鼠血清样品中视黄醇和视黄酸均分离良好,视黄醇质量浓度在50-1000ng·mL-1(R2=
目的:研究大川芎方配伍前后对硝酸甘油致实验性偏头痛模型大鼠脑组织中5-羟色胺及谷氨酸、天门冬氨酸含量的影响.方法:采用HPLC-FLD法直接测定不同时间点各组脑组织中5-羟色胺含量,另外采用丹磺酰氯柱前衍生HPLC-FLD法测定不同时间点各组脑组织中谷氨酸、天门冬氨酸的含量.结果:在15min及30min时大川芎方组中脑组织的5-HT含量明显高于天麻组(P<0.05);在15min、30min、6
Objective: To survey the bacterial resistance of antibiotics in a teaching hospital.Methods: A retrospective study was carried out for antibiotic susceptibility of bacteria in a university hospital fr
目的:研究五指毛桃提取物对拘束负荷诱发小鼠应激性肝损伤的保护作用.方法:五指毛桃提取物(125,250及500mg·kg–1)连续给药4天,18h拘束负荷诱发小鼠应激性肝损伤,分别用赖氏法测定小鼠血浆丙氨酸氨基转移酶(ALT)活性、硫代巴比妥酸法测定肝组织丙二醛(MDA)含量、Griess化学法测定一氧化氮(NO)含量、荧光酶标仪测定肝组织抗氧化能力指数(ORAC)、HPLC法测定谷胱甘肽(GSH
目的:观察胰高血糖素样肽-1(GLP-1)及其受体激动剂Exendin-4(EX-4)对体外培养大鼠骨髓间充质干细胞(BMSCs)增殖与成骨分化的影响.方法:取大鼠股骨及胫骨全骨髓,采用贴壁法分离骨髓间充质干细胞,扩增传代至第三代,根据分组,在成骨诱导培养体系中添加含不同浓度(10-9-10-7mol/L)GLP-1或EX-4的条件培养液,MTT法检测细胞增殖能力;测定碱性磷酸酶(ALP)活性;碱
目的:研究熄风舒络胶囊对血瘀性脑缺血大鼠脑组织形态学、血液流变学及血管相关调节因子的作用.方法:采用多次肌内注射地塞米松后结扎双侧颈总动脉复制血瘀性脑缺血大鼠模型,检测大鼠体重变化、血液粘度、血管相关调节因子及脑组织病理学,研究熄风舒络胶囊对实验性脑缺血的保护作用,探讨作用机制.结果:熄风舒络胶囊(3.56g/kg)能明显减缓模型大鼠的体重减小(P<0.05),1.78~3.56g/kg熄风舒络胶
目的:采用烟酰胺(Nicotinamide,NAA)联合链脲佐菌素(streptozotocin,STZ)诱导方法建立2型糖尿病大鼠模型,并摸索NAA的最佳保护剂量.方法:将体重220-250g的雄性wistar大鼠70只随机分为7组,分别为对照组(A组:腹腔注射生理盐水,15min后尾静脉注射柠檬酸缓冲液)和造模组(B-G组:分别先腹腔注射100、120、140、160、180、200mg/kg
目的:探讨天麻和钩藤中两种活性组分配伍对血管内皮细胞的保护及其作用机制.方法:构建同型半胱氨酸诱导的人静脉内皮细胞ECV304损伤模型,加入天麻素:钩藤碱配比为1∶5,测定细胞存活率,NO生成量,Caveolin-1表达量.结果:与模型组比较,实验组浓度范围在0.5μg·mL-1~500μg·mL-1的配伍药物作用损伤模型36h后,细胞相对活力提高,MDA、LDH释放量下降,NO生成量增加,Cav
目的:本研究旨在探索HGPRT活性及基因多态性与AZA所致不良反应的相关性,为临床合理使用AZA提供理论依据.方法:用本实验室建立的HPLC法测定入选样本的HGPRT活性,直接测序法测定HGPRT IVS6-12C>T的基因型,结合受试者不良反应发生情况,分析HGPRT活性及多态性与AZA所致不良反应的相关性.结果:86例肾移植受者HGPRT活性范围为44.59-262.16U,平均为100.17